stockrow
Friday 6 November 2026
Export COSM’s income statement to Excel — free account
Cosmos Health Inc.
COSM Healthcare Medical Distribution
Cosmos Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.3 million, up 19.9% from fiscal 2024.
- Revenue
- +28.8%
- EPS
- 0.00%
- Free cash flow
- +9.39%
- Total debt
- +15.3%
Quarter to June 2026, against a year earlier
0.31
0.02
+6.90%
Follow COSM
Alert me
Cosmos Health Inc. (COSM) P/E ratio
Cosmos Health Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 97.0× (March 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 3.3× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 38 more quarters | Free account |
Against its own ten years
Low 0.0×
High 97.0×
Ten-year median
0.0×
Current reading's percentile
95
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| MEDS DataMeds AI, Inc compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| SNYRQ Synergy CHC Corp. compare | n/m |
| COSM Cosmos Health Inc. | n/m |
| HSIC Henry Schein, Inc. compare | 22.8× |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)